Nordic Pharmaceutical Company SAC Pharmaceutical Import Profile — Peru (DGFT 2022–2026)

Name: Nordic Pharmaceutical Company SAC Pharmaceutical Import Records from India — 4 Products, $7.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nordic Pharmaceutical Company SAC — Pharmaceutical Importer Profile (2026) | 4 Products, $7.3M Trade | TransData Nexus

Nordic Pharmaceutical Company SAC

Pharmaceutical Importer · Peru · Cardiovascular Focus · $7.3M Total Trade · DGFT Verified

Nordic Pharmaceutical Company SAC is a pharmaceutical importer based in Peru with a total trade value of $7.3M across 4 products in 3 therapeutic categories. Based on 145 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Nordic Pharmaceutical Company SAC sources from 19 verified Indian suppliers, with Gland Pharma Limited accounting for 40.1% of imports.

Nordic Pharmaceutical Company SAC — Import Portfolio & Supplier Network

Nordic Pharmaceutical Company SAC import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Nordic Pharmaceutical Company SAC?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Gland Pharma Limited	$2.7M	64	40.1%
Macleods Pharmaceuticals Limited	$1.3M	85	19.2%
Lyka Labs Limited

What Formulations Does Nordic Pharmaceutical Company SAC Import?

Formulation	Value	Ships
Heparin sodium injection BP 25000 IU/5ML	$800.0K	16
Heparin sodium injectionbp 25000 IU/5ML	$600.0K	12
Low molecular weight heparin enoxaparinsodium injection USP, 60MG in 0.6ML pre-filled	$343.8K	8
Drugs and pharmaceuticals harmless	$184.7K	6
Linezolid i.v. injection- nirzolid 300ML	$140.4K	5
Sodium chloride intravenous infusion	$127.0K	3
Ensufer 100MG/5ML (20MG/ML)	$113.4K	5
Omepra - n 40MG (omeprazol 40MG)	$107.8K	7
Dolutegravir 50MG lamivudine 300MG	$100.0K	2
Drugs and pharmaceuticals harmless medicines isoniazid tablets BP 100MG	$100.0K	2
Pinephed (noradrenaline injection BP 4MG/4ML)	$100.0K	2
Heparin injection BP,25000iu/5ML,5ML	$100.0K	2
Low molecular weight heparin enoxaparinsodium injection USP,40MG in 0.4ML pre-filled	$100.0K	2
Sodium chloride 0 9 solution for iv infusion 1000 ML	$90.6K	5
Low molecular weight heparin enoxaparinsodium injection USP 60MG in 0.6ML pre-filled	$89.0K	2

Nordic Pharmaceutical Company SAC imports 240 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Heparin	Cardiovascular	$3.3M	66	0.8%	12
2	Sodium	Nutritional Supplements	$1.4M	29	0.4%	13
3	Enoxaparin	Cardiovascular	$1.3M	26	0.5%	13
4	Syringe	Medical Devices & Diagnostics	$1.2M	24	0.5%	18

Nordic Pharmaceutical Company SAC imports 4 pharmaceutical products across 3 categories into Peru totaling $7.3M.

Nordic Pharmaceutical Company SAC — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Nordic Pharmaceutical Company SAC is a Peruvian pharmaceutical company established on February 5, 2002, with its headquarters located at Jr. Patricio Iriarte 279, Urb. Santa Catalina, La Victoria, Lima. The company specializes in the wholesale distribution of pharmaceutical and medicinal products, cosmetics, and personal care items. Over the years, Nordic Pharmaceutical has built a solid presence in both the public institutional sector and the private market, with an annual turnover of approximately nine million dollars.

The company's portfolio encompasses six key therapeutic areas: cardiovascular, hematology, oncology, gastroenterology, anti-infectives and retrovirals, and urology. Nordic Pharmaceutical is committed to providing accessible, high-quality medications to patients in Peru, collaborating closely with healthcare professionals to ensure effective therapeutic solutions.

2Distribution Network

Nordic Pharmaceutical Company SAC operates a centralized distribution network from its headquarters in Lima, Peru. While specific details about warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive import activities suggest a well-established infrastructure capable of managing a diverse product portfolio. The distribution network primarily serves the Peruvian market, ensuring that medications reach various healthcare facilities and pharmacies across the country.

3Industry Role

Nordic Pharmaceutical Company SAC functions as a primary wholesaler in Peru's pharmaceutical supply chain. The company imports finished pharmaceutical formulations from international suppliers, including a significant number from India, and distributes these products to healthcare providers and pharmacies throughout Peru. By focusing on the wholesale distribution of imported finished formulations, Nordic Pharmaceutical plays a crucial role in ensuring the availability of a wide range of therapeutic options to meet the diverse needs of the Peruvian healthcare system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Nordic Pharmaceutical Company SAC

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Nordic Pharmaceutical Company SAC's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a select group of Indian suppliers. The top five suppliers account for 100% of the company's imports, indicating a strategic choice to maintain strong, stable relationships with these partners. This concentrated sourcing approach can lead to benefits such as favorable pricing, consistent product quality, and reliable supply chains. However, it also presents risks, including potential vulnerabilities to supply disruptions or changes in supplier dynamics. The company's reliance on a limited number of suppliers necessitates robust risk management strategies to mitigate potential impacts on operations.

2Supply Chain Resilience

The resilience of Nordic Pharmaceutical Company SAC's supply chain is closely tied to its concentrated sourcing model. While the company benefits from strong relationships with its primary suppliers, this dependence also means that any disruptions—such as production issues, regulatory changes, or geopolitical events affecting supplier countries—could significantly impact the company's ability to maintain a consistent product supply. To enhance supply chain resilience, Nordic Pharmaceutical may consider diversifying its supplier base, establishing contingency plans, and closely monitoring the regulatory compliance and operational stability of its key suppliers.

Importing Pharmaceuticals into Peru — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Peru

1Regulatory Authority & Framework

In Peru, the regulatory authority responsible for overseeing pharmaceutical imports and ensuring the safety and efficacy of medications is the General Directorate of Medicines, Supplies, and Drugs (DIGEMID), which operates under the Ministry of Health. DIGEMID is tasked with evaluating and approving pharmaceutical products, including those imported from countries like India. The regulatory framework governing pharmaceutical imports in Peru includes requirements for Good Manufacturing Practice (GMP) certification, product registration, and compliance with labeling and packaging standards. These regulations are designed to protect public health by ensuring that all pharmaceutical products meet established quality standards before they are distributed within the country.

2Import Licensing & GMP

Import licensing requirements in Peru stipulate that all pharmaceutical products, including those imported by companies like Nordic Pharmaceutical Company SAC, must be registered with DIGEMID prior to distribution. This registration process involves submitting detailed product information, including evidence of GMP certification from the manufacturing facility. DIGEMID recognizes GMP certifications from reputable international bodies, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), facilitating the acceptance of products manufactured under these standards. Additionally, companies must obtain wholesale distribution authorization to legally distribute pharmaceutical products within Peru.

Nordic Pharmaceutical Company SAC — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Nordic Pharmaceutical Company SAC's focus on importing products in the cardiovascular, nutritional supplements, and medical devices & diagnostics categories aligns with the company's strategic objectives to address prevalent health concerns in Peru. The cardiovascular category, comprising 63.4% of imports, reflects the high incidence of heart-related diseases in the country. Nutritional supplements (20.0%) and medical devices & diagnostics (16.6%) are also critical areas, addressing the growing demand for preventive healthcare and diagnostic tools. By concentrating on these therapeutic areas, Nordic Pharmaceutical aims to meet the specific health needs of the Peruvian population, thereby enhancing its market position and fulfilling its mission to provide accessible, high-quality healthcare solutions.

2Sourcing Profile

Nordic Pharmaceutical Company SAC's sourcing strategy emphasizes the importation of generic drug formulations, primarily from India, to offer cost-effective therapeutic options to the Peruvian market. The company's preference for finished pharmaceutical formulations over raw active pharmaceutical ingredients (APIs) allows for a more streamlined supply chain and ensures that products are ready for distribution upon arrival. India's well-established pharmaceutical manufacturing sector, known for its adherence to international quality standards, makes it a reliable source for these formulations. This sourcing approach enables Nordic Pharmaceutical to maintain a diverse product portfolio while managing costs effectively.

Seller's Guide — How to Become a Supplier to Nordic Pharmaceutical Company SAC

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Nordic Pharmaceutical Company SAC, given the company's concentrated sourcing pattern and the high demand for pharmaceutical products in Peru. Potential gaps in Nordic Pharmaceutical's current sourcing include the need for additional suppliers to mitigate risks associated with supply chain concentration and to meet the growing demand for specific therapeutic areas. Indian exporters can capitalize on this opportunity by offering high-quality products, competitive pricing, and reliable delivery schedules, thereby establishing strong partnerships with Nordic Pharmaceutical and expanding their presence in the Peruvian market.

2Requirements & Qualifications

Indian exporters seeking to supply Nordic Pharmaceutical Company SAC and the Peruvian market must ensure that their products comply with Peru's regulatory requirements. This includes obtaining GMP certification from recognized international bodies such as WHO or PIC/S, registering products with DIGEMID, and adhering to labeling and packaging standards in Spanish. Additionally, exporters should be prepared to provide documentation supporting the safety, efficacy, and quality of their products, as these are critical factors in the approval process. Maintaining consistent product quality and compliance with regulatory standards is essential for establishing and sustaining business relationships in Peru.

Frequently Asked Questions — Nordic Pharmaceutical Company SAC

What products does Nordic Pharmaceutical Company SAC import from India?

Nordic Pharmaceutical Company SAC imports 4 pharmaceutical products across 3 categories. Top imports: Heparin ($3.3M), Sodium ($1.4M), Enoxaparin ($1.3M), Syringe ($1.2M).

Who supplies pharmaceuticals to Nordic Pharmaceutical Company SAC from India?

Nordic Pharmaceutical Company SAC sources from 19 verified Indian suppliers. The primary supplier is Gland Pharma Limited (40.1% of imports, $2.7M).

What is Nordic Pharmaceutical Company SAC's total pharmaceutical import value?

Nordic Pharmaceutical Company SAC's total pharmaceutical import value from India is $7.3M, based on 145 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Nordic Pharmaceutical Company SAC focus on?

Nordic Pharmaceutical Company SAC imports across 3 categories. The largest: Cardiovascular (63.4%), Nutritional Supplements (20.0%), Medical Devices & Diagnostics (16.6%).

Get Full Nordic Pharmaceutical Company SAC Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Nordic Pharmaceutical Company SAC

Nordic Pharmaceutical Company SAC — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Nordic Pharmaceutical Company SAC?

What Formulations Does Nordic Pharmaceutical Company SAC Import?

What Products Does Nordic Pharmaceutical Company SAC Import?

Top Products by Import Value

Nordic Pharmaceutical Company SAC Therapeutic Categories — 3 Specializations